ABBV vs BOLD · P/E 81, rev $61.16B vs P/E 0.1, $24.6M cap
AbbVie Inc (ABBV) versus Boundless Bio, Inc. Common Stock (BOLD) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
BOLD does not have a complete income-statement cache yet.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. BOLD currently screens at market cap $24.6M and trailing P/E 0.1.
Not investment advice. Open the ABBV and BOLD stock pages for the full models.
Not investment advice.